These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30443371)

  • 1. Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare.
    Brandt J; Shearer B; Morgan SG
    J Pharm Policy Pract; 2018; 11():28. PubMed ID: 30443371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2018 decision to establish an Advisory Council on adding pharmaceuticals to universal health coverage in Canada.
    Grignon M; Longo CJ; Marchildon GP; Officer S
    Health Policy; 2020 Jan; 124(1):7-11. PubMed ID: 31761273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada".
    Gagnon MA
    Int J Health Policy Manag; 2021 Mar; 10(3):168-171. PubMed ID: 32610789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separated at Birth: The Politics of Pharmacare for All in Canada and Medicare for All in the United States Comment on "Universal Pharmacare in Canada".
    Tuohy CH
    Int J Health Policy Manag; 2021 Mar; 10(3):162-164. PubMed ID: 32610786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare".
    Rawson NSB
    Int J Health Policy Manag; 2020 Dec; 9(12):524-527. PubMed ID: 32610769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal Pharmacare in Canada: A Prescription for Equity in Healthcare.
    Hajizadeh M; Edmonds S
    Int J Health Policy Manag; 2020 Mar; 9(3):91-95. PubMed ID: 32202091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010.
    Daw JR; Morgan SG
    Health Policy; 2012 Jan; 104(1):19-26. PubMed ID: 21978939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal prescription drug coverage in Canada: Long-promised yet undelivered.
    Morgan SG; Boothe K
    Healthc Manage Forum; 2016 Nov; 29(6):247-254. PubMed ID: 27744279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated cost of universal public coverage of prescription drugs in Canada.
    Morgan SG; Law M; Daw JR; Abraham L; Martin D
    CMAJ; 2015 Apr; 187(7):491-497. PubMed ID: 25780047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-Romanow pharmacare: last-dollar first...first-dollar lost?
    Morgan SG; Willison DJ
    Healthc Pap; 2004; 4(3):10-20. PubMed ID: 15114064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What can the Canadians and Americans learn from each other's health care systems?
    Weil TP
    Int J Health Plann Manage; 2016 Jul; 31(3):349-70. PubMed ID: 27469581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacare in Canada: The paediatric perspective.
    McLaughlin T; Jong G'; Gilpin A; Hepburn CM
    Paediatr Child Health; 2020 Mar; 25(2):113-124. PubMed ID: 32189975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who's the fairest of them all? Which provincial pharmacare model would best protect Canadians against catastrophic drug costs?
    Coombes ME; Morgan SG; Barer ML; Pagliccia N
    Healthc Q; 2004; 7(4):suppl 13-9. PubMed ID: 15540402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. It Won't Be Easy: How to Make Universal Pharmacare Work in Canada.
    Lewis S
    Int J Health Policy Manag; 2020 Jan; 9(1):1-5. PubMed ID: 31902189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public-private partnership alternative for a national pharmacare program in Canada.
    Nauenberg E; Yurga E
    J Pharm Policy Pract; 2023 Feb; 16(1):21. PubMed ID: 36747233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six Myths About Pharmacare.
    Lexchin J
    Health Law Can; 2017 Feb; 37(2-3):44-51. PubMed ID: 30005520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of health services utilization by prescription drug coverage and immigration category in Ontario, Canada.
    Antonipillai V; Guindon GE; Sweetman A; Baumann A; Wahoush O; Schwartz L
    Health Policy; 2021 Oct; 125(10):1311-1321. PubMed ID: 34226053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. After More Than 50 Years, Pharmacare (and Dental Care) are Coming to Canada.
    Lexchin J
    Int J Health Serv; 2022 Jul; 52(3):341-346. PubMed ID: 35535406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.
    Morgan SG; Li W; Yau B; Persaud N
    CMAJ; 2017 Feb; 189(8):E295-E302. PubMed ID: 28246223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.